Ilya Pharma will present new data and development plans for our ILP100 candidate at IBD Innovate, organised by Chrones and Colitis Foundation, NYC 4th of December

IBD INNOVATE: Product Development for Crohn’s & Colitis™. The Symposium is co-hosted by Eli Lilly and Celgene.

Ilya Pharma selected top Innovator and will present at the New England Venture Summit December 4 in Boston

Ilya Pharma will present clinical developments at Bio Investor Forum SF 22-23 October

Ilya Pharma - one of the selected 30 most innovative companies, RESI2019, Boston Biotech Week

Ilya Pharma selected to present at Biopharm America/Boston Biotech week 9-12 September

Ilya Pharma will present at Nordic Life Science Days 11-12 September, Malmö

Nordic Life Science Days 11-12 September in Malmö gathers SMEs and Big Pharma.

Ilya Pharma will present at the 29th Conference of the European Wound Management Association, Gothenburg 5-7 June

Ilya Pharma winner at Hello Tomorrow Global Challenge 2019

First selected as top 80 from the 4500 applications from companies all over the world aiming for innovative solutions to the sustainable goals of the UN Agenda 2030 to then win the wellbeing track sponsored by Loreal.

Hello Tomorrow Investor day, Paris 13th March

The event is exclusive for the selected top 100 companies in deep tech, globally. Ilya Pharma is in the wellbeing track and gets the opportunity to present for and meet with specially invited global pharma and biotech investors.

Advanced Wound Care presentation at Redeye

Advanced wound care has been identified by Redeye as segment attaining a strong interest for investments. Four growth stage companies have been invited to present at the Advanced Wound Care-seminar in Stockholm. Ilya Pharma, PROMORE, S2 MEDICAL and RLS GLOBAL, all within the AWC space in Medtech and Pharma.